InvestorsHub Logo
Followers 18
Posts 1093
Boards Moderated 0
Alias Born 05/12/2007

Re: None

Monday, 09/01/2008 9:11:30 PM

Monday, September 01, 2008 9:11:30 PM

Post# of 116
Has ONXX given any guidance as to when we should expect interim/final analysis for the Nexavar Phase III trial in melanoma? It appears to be fully enrolled according to clinicaltrials.gov??

Also, the gov't website says PFS is primary endpoint, but the corporate presentation slides say OS is the primary endpoint. Which is it?

Thanks for any help!